XORTX Therapeutics Inc. submitted a Form 6-K on April 8, 2024, reporting that it meets SEC requirements for foreign private issuers, and confirmed its filing status under Form 20-F.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.